Research Topic · Peer-Reviewed

Vaccine Development

Vaccine development is the systematic process of designing, producing, and evaluating biological preparations that train the immune system to recognize and defend against specific pathogens. It progresses from antigen discovery and platform selection through preclinical testing to phased clinical trials assessing sa…

Curated from this journal's research 📚 11 peer-reviewed articles cited Cited 17× across the literature 🔖 ISSN 2691-8862 🗓 Reviewed July 2026

Overview

Vaccine development is the systematic process of designing, producing, and evaluating biological preparations that train the immune system to recognize and defend against specific pathogens. It progresses from antigen discovery and platform selection through preclinical testing to phased clinical trials assessing safety, immunogenicity, and efficacy, followed by regulatory review, manufacturing, and post-licensure surveillance. Vaccine platforms include inactivated and live-attenuated organisms, protein subunit and epitope-based formulations, and nucleic-acid and vector approaches, often combined with adjuvants and delivery systems such as nanoparticle carriers to enhance and direct the immune response. Effective development must elicit durable protective immunity, frequently by inducing neutralizing antibodies and cellular responses, while ensuring tolerability across diverse populations. Beyond the laboratory, successful immunization programs depend on uptake, which is shaped by vaccine hesitancy, access, and the attitudes of healthcare workers and the public. Research relevant to this topic addresses COVID-19 vaccine development and its prospects and challenges, computational prediction of B-cell epitopes, nanoadjuvant systems for tuberculosis vaccination, and the characterization of specific vaccine candidates, alongside studies of vaccine hesitancy and uptake among healthcare workers and people living with HIV. Together these strands span the scientific, immunological, and behavioural dimensions that determine whether candidate vaccines translate into population-level protection.

Research published in this journal

11 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2021

Characterization of the Vaccine Abdala

Pino Marrero KatiaCorresponding author
Holguin's university of medical sciences, Cuba.
Current Viruses and Treatment Methodologies doi:10.14302/issn.2691-8862.jvat-21-3999

How this research is being cited

The 11 articles above have been cited 17 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Vaccine Development, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Current Viruses and Treatment Methodologies (ISSN 2691-8862).

Journal editorial board
Dr. Anantha Harijith · United States

This page summarises published research for orientation; it is not medical or professional advice.